Table 7.
Summary of participants’ suggestion on research areas and preferred collaborator for pharmacy practice-based research.
| Variables | Respondents’ site of practice, N (%) | |
|---|---|---|
| Community | Hospital | |
| Suggested research areas | N = 248 | N = 196 |
| Pharmaceutical care | 81 (32.7) | 65 (33.2) |
| Medication Therapy Management | 82 (33.1) | 60 (30.6) |
| Pharmacovigilance (adverse reaction documentation) | 76 (30.6) | 63 (32.1) |
| Pharmacy/operation management | 4 (1.6) | 3 (1.5) |
| Drug abuse | 4 (1.6) | NM |
| Self-medication | 1 (0.4) | NM |
| Drug compliance/adherence | NM | 2 (1.0) |
| Rational prescription and drug use | NM | 2 (1.0) |
| New drug development | NM | 1 (0.5) |
| Preferred collaborator(s) for research in the respective area of practice | N = 169 | N = 159 |
| Academic pharmacist | 66 (39.1) | 57 (35.8) |
| Physician in the practice locality | 54 (32.0) | 42 (26.4) |
| Regulatory pharmacist | 38 (22.5) | 33 (20.8) |
| Other members of the healthcare team (nurses, laboratory scientists) | 5 (3.0) | 16 (10.1) |
| Non-governmental organisation, patients/caregivers and community | 4 (2.4) | 11 (6.9) |
| Medical representative | 2 (1.2) | NM |
Responses are giving in combinations in some cases; NM = not mention, N = number